Morphine Sulfate 63323-0454-01
- Manufacturer
- Fresenius Kabi Usa, Llc
- Dosage Form
- Injection, Solution
- Route
- Intramuscular And Intravenous
- Product Type
- Human Prescription Drug
- DEA Schedule
- Schedule CII
- Marketing Start
- April 10, 2018
- Listing Expires
- December 31, 2026
- Application
- NDA204223
Active Ingredients
| Ingredient | Strength |
|---|---|
| Morphine Sulfate | 4 mg/mL |
Drug Class
Full Opioid Agonists [MoA]Opioid Agonist [EPC]
Selected Package
63323-0454-01Selected25 VIAL, SINGLE-DOSE in 1 BOX (63323-454-01) / 1 mL in 1 VIAL, SINGLE-DOSE (63323-454-00)